Skip to main content
Top
Published in: Internal and Emergency Medicine 3/2017

01-04-2017 | CE - MEDICAL ILLUSTRATION

Dupuytren’s contracture… or is it?

Authors: Arjun Gupta, Nivedita Arora, Samar Harris, Harris V. Naina

Published in: Internal and Emergency Medicine | Issue 3/2017

Login to get access

Excerpt

A 90-year-old previously healthy man presented with progressive thickening of the skin of his left hand over the prior 4 months. It had become severe enough to limit movements of the fingers of his hand. He had received localized steroid injections for a presumptive diagnosis of ‘Dupuytren’s contracture’ with no symptomatic improvement. He reported no prior or current alcohol use, no cigarette smoking, and did not take any scheduled medications. He reported no trauma to the hands, occupational or accidental. Vital signs were unremarkable but examination of the left hand showed a 6 cm mass involving the thenar eminence partially obliterating the first webspace, with atrophic and shiny overlying skin (Fig. 1a). Basic laboratory studies including blood counts, renal, liver and thyroid functions were within normal limits. The patient was referred to a hand surgeon, and a subtotal resection of the mass was performed. Histopathology demonstrated a nodular proliferation of medium–large-sized, aberrant T-lymphoid cells, concerning for a lymphomatous process. A positron emission tomography (PET) scan showed diffuse uptake in the left hand without systemic uptake (Fig. 1b). Based on the microscopic features and PET findings of isolated hand involvement, a diagnosis of solitary acral CD4 T cell lymphoma (TCL) was made. Despite localized radiation therapy, oral vorinostat (histone deacetylase inhibitor) treatment and ultimately amputation of the hand due to gangrene, he died a few weeks later.
Literature
1.
go back to reference Gudmundsson KG, Jonsson T, Arngrimsson R (2003) Guillaume Dupuytren and finger contractures. Lancet 362(9378):165–168CrossRefPubMed Gudmundsson KG, Jonsson T, Arngrimsson R (2003) Guillaume Dupuytren and finger contractures. Lancet 362(9378):165–168CrossRefPubMed
3.
go back to reference Lim YL, Pack HS, Park JE, Oh JR, Kong JH (2015) Extranodal natural killer/T-cell lymphoma of the tenosynovium of the hand. Korean J Intern Med 30(1):122–124CrossRefPubMed Lim YL, Pack HS, Park JE, Oh JR, Kong JH (2015) Extranodal natural killer/T-cell lymphoma of the tenosynovium of the hand. Korean J Intern Med 30(1):122–124CrossRefPubMed
4.
go back to reference Ally MS, Robson A (2014) A review of the solitary cutaneous T-cell lymphomas. J Cutan Pathol 41(9):703–714CrossRefPubMed Ally MS, Robson A (2014) A review of the solitary cutaneous T-cell lymphomas. J Cutan Pathol 41(9):703–714CrossRefPubMed
Metadata
Title
Dupuytren’s contracture… or is it?
Authors
Arjun Gupta
Nivedita Arora
Samar Harris
Harris V. Naina
Publication date
01-04-2017
Publisher
Springer International Publishing
Published in
Internal and Emergency Medicine / Issue 3/2017
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-016-1492-9

Other articles of this Issue 3/2017

Internal and Emergency Medicine 3/2017 Go to the issue

IM - CASE RECORD

A painful diagnosis

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine